CN Patent

CN101005831B — 包含普拉克索或其可药用盐的延长释放片剂

Assigned to Boehringer Ingelheim International GmbH · Expires 2010-11-10 · 16y expired

What this patent protects

本发明涉及在基质中包含普拉克索或其可药用盐的延长释放片剂，所述基质包含至少两种水溶胀性聚合物，其中所述聚合物的一种为预胶化淀粉，且其中所述聚合物的另一种为阴离子聚合物。

USPTO Abstract

本发明涉及在基质中包含普拉克索或其可药用盐的延长释放片剂，所述基质包含至少两种水溶胀性聚合物，其中所述聚合物的一种为预胶化淀粉，且其中所述聚合物的另一种为阴离子聚合物。

Drugs covered by this patent

pramipexole-dihydrochloride (PRAMIPEXOLE DIHYDROCHLORIDE)

Patent Metadata

Patent number: CN101005831B
Jurisdiction: CN
Classification: —
Expires: 2010-11-10
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim International GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.